2026 NPPES data Hematology & Oncology Physician NPI 1831167071 M.D.
Verify on CMS →

MONTY METCALFE, M.D.

Hematology & Oncology Physician in LEXINGTON, Kentucky. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
222
Medicare Part D claims · 64 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MONTY METCALFE, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in LEXINGTON, Kentucky with a Medicare Part D prescribing footprint of 222 claims across 64 beneficiaries — 6% brand-name prescribing .

What stands out: MONTY METCALFE, M.D. filed 222 Medicare Part D claims in 2023 across LEXINGTON, Kentucky. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MONTY METCALFE, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MONTY METCALFE, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 03/14/2006

NPI 1831167071

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

222 74% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Kentucky

How Hematology & Oncology Physician compares to other specialties among Kentucky providers

Kentucky providers

Hematology & Oncology Physician share within Kentucky

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Kentucky

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MONTY METCALFE, M.D. is a Hematology & Oncology Physician provider practicing in LEXINGTON, Kentucky, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1831167071. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MONTY METCALFE, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 701 BOB O LINK DR, LEXINGTON, KY, 40504, with a listed phone of (859) 224-3194. NPI 1831167071 was issued on 03/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what METCALFE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 222 prescription claims written by this provider, covering 64 Medicare beneficiaries and totaling roughly $99K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

701 BOB O LINK DR
LEXINGTON, KY 40504

Provider Details

NPI 1831167071
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 03/14/2006

Brand vs generic prescribing mix · Generic-heavy

MONTY METCALFE, M.D. — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 222 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

222
Total Claims
$99K
Total Drug Cost
64
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
367
Total Day Supply
10,465
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$6K
Generic Drug Cost
$93K

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.80
Gender Split
73% female / 27% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
31
Ondansetron Hcl
13
Duloxetine Hcl
11
Hydroxyurea
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MONTY METCALFE, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MONTY METCALFE, M.D.'s 222 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Kentucky

Other clinicians with the same primary specialty enrolled in Kentucky, drawn from the same CMS NPPES roster as METCALFE.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MONTY METCALFE, M.D.'s specialty?
MONTY METCALFE, M.D. specializes in Hematology & Oncology Physician and practices in LEXINGTON, Kentucky. Credentials: M.D..
How much does MONTY METCALFE, M.D. prescribe under Medicare Part D?
In 2023, MONTY METCALFE, M.D. wrote 222 Medicare Part D claims totaling $99K in drug costs for 64 beneficiaries.
Where is MONTY METCALFE, M.D. located?
MONTY METCALFE, M.D. is located at 701 BOB O LINK DR, LEXINGTON, KY, 40504. Phone: (859) 224-3194.
What is MONTY METCALFE, M.D.'s NPI number?
MONTY METCALFE, M.D.'s National Provider Identifier (NPI) is 1831167071, issued on 03/14/2006.
Does MONTY METCALFE, M.D. prescribe more brand-name or generic drugs?
MONTY METCALFE, M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $6K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MONTY METCALFE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MONTY METCALFE, M.D.'s most frequently prescribed drugs include Anastrozole, Ondansetron Hcl, Duloxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MONTY METCALFE, M.D. accept Medicare?
MONTY METCALFE, M.D. appears in CMS Medicare data with 222 Part D claims and 64 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MONTY METCALFE, M.D.'s credentials?
MONTY METCALFE, M.D.'s NPI is 1831167071 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology